Gyre Therapeutics (GYRE) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $5.9 million.
- Gyre Therapeutics' Profit After Tax rose 10784.31% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 11412.47%. This contributed to the annual value of $17.9 million for FY2024, which is 12093.82% up from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Profit After Tax is $5.9 million, which was up 10784.31% from $1.6 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Profit After Tax ranged from a high of $51.6 million in Q2 2022 and a low of -$101.0 million during Q4 2023
- Over the past 5 years, Gyre Therapeutics' median Profit After Tax value was $1.6 million (recorded in 2025), while the average stood at -$7.4 million.
- As far as peak fluctuations go, Gyre Therapeutics' Profit After Tax crashed by 45361.46% in 2021, and later surged by 35909.27% in 2022.
- Quarter analysis of 5 years shows Gyre Therapeutics' Profit After Tax stood at -$20.3 million in 2021, then tumbled by 37.23% to -$27.9 million in 2022, then plummeted by 261.95% to -$101.0 million in 2023, then skyrocketed by 100.56% to $569000.0 in 2024, then skyrocketed by 943.23% to $5.9 million in 2025.
- Its Profit After Tax was $5.9 million in Q3 2025, compared to $1.6 million in Q2 2025 and $3.7 million in Q1 2025.